nevirapine has been researched along with thiazoles in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gozlan, M | 1 |
Arakaki, R; Baba, M; Jinno, S; Nakashima, H; Premanathan, M; Ramanan, S; Yamashita, S | 1 |
Baba, M; Fujii, M; Fujiwara, M; Fujiyasu, J; Hatta, T; Inoue, H; Kageyama, S; Kodama, E; Koga, H; Kontani, T; Kurihara, H; Masuda, N; Matsuoka, M; Moritomo, A; Nakahara, H; Ohgami, T; Ohta, M; Orita, M; Shigeta, S; Shimizu, Y; Sudo, K; Suzuki, H; Yamamoto, O; Yokota, T | 1 |
Ariën, KK; Heyndrickx, L; Michiels, J; Quiñones-Mateu, ME; Selhorst, P; Terrazas-Aranda, K; Vanham, G; Vazquez, AC; Vereecken, K; Weber, J | 1 |
Shegokar, R; Singh, KK | 1 |
Ahn, J; Cechetto, J; Choi, I; Han, SJ; Jo, M; Jo, S; Ju, MK; Kim, J; Kim, TH; Kim, Y; Ko, Y; Lee, D; Liuzzi, M; Nam, J; No, Z; Ok, T; Park, C; Park, Y; Seo, M; So, W; Sommer, P; Yoon, J | 1 |
6 other study(ies) available for nevirapine and thiazoles
Article | Year |
---|---|
Update on HIV transmission and pathogenesis.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Disease Models, Animal; Genes, env; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; HLA-A Antigens; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Macaca; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Simian Immunodeficiency Virus; Thiazoles; Time Factors; Valine; Virulence; Virus Latency; Virus Replication | 1995 |
3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cysteine; Drug Resistance; Fishes; HIV Core Protein p24; HIV Protease; HIV-1; Humans; Molecular Structure; Naphthalenes; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thiazolidines; Virus Replication | 1998 |
Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides.
Topics: Benzenesulfonates; Binding Sites; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Molecular Structure; Nevirapine; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfonamides; Thiazoles; Virus Replication | 2004 |
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.
Topics: Alkynes; Anilides; Anti-Infective Agents; Benzoxazines; Cell Line; Cells, Cultured; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Furans; Genotype; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thioamides; Thiourea | 2011 |
Nevirapine nanosuspensions for HIV reservoir targeting.
Topics: Animals; Anti-HIV Agents; Cell Line; Cell Survival; Chelating Agents; Coloring Agents; Disease Reservoirs; Electrochemistry; HIV-1; In Vitro Techniques; Infusions, Parenteral; Isotope Labeling; Kidney; Macrophages; Male; Mice; Microscopy, Atomic Force; Nanoparticles; Nevirapine; Particle Size; Permeability; Radionuclide Imaging; Rats; Solubility; Suspensions; Tetrazolium Salts; Thiazoles; Tissue Distribution; Urinary Bladder; X-Ray Diffraction | 2011 |
A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.
Topics: Animals; Cell Line, Tumor; Drug Stability; HIV Reverse Transcriptase; HIV-1; Humans; Microsomes, Liver; Models, Molecular; Nevirapine; Pyrimidinones; Rats; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Virus Replication | 2012 |